In addition, GWAS results illustrate that IREB2 has been shown to be associated COPD and the expression of its protein product IRP2 is altered in lung cancer patients carrying lung cancer (Fehringer et al., 2012). The gene discussed is IREB2; the disease is lung carcinoma.